Study of ELA026 for Treatment of Secondary Hemophagocytic Lymphohistiocytosis in Patients with Lymphoma Who Have Not Received Previous Treatment
- Substances:ELA026
Germany- Participants:0–17 years · 18–64 years · 65+ years
- Substances:ELA026
Rare diseases
Investigational molecules
Locations
GermanyStudy of patritumab deruxtecan versus drug combination in patients with hormone receptor-positive, HER2-negative advanced or metastatic breast cancer
FranceStudy of NBI-1065845 as add-on treatment to prevent depression relapse in adults with Major Depressive Disorder who responded to initial treatment
BulgariaStudy of new chickenpox vaccine and measles-mumps-rubella vaccine given by intramuscular injection in healthy children aged 12 to 15 months
BelgiumStudy of raludotatug deruxtecan, ifinatamab deruxtecan and docetaxel in patients with previously treated stage IV squamous non-small cell lung cancer
GermanyStudy of inavolisib, letrozole and ribociclib in untreated early-stage breast cancer patients with PIK3CA mutation
GermanyStudy of elexacaftor, tezacaftor and ivacaftor combination therapy to evaluate blood levels in patients with Cystic Fibrosis
ItalyStudy of ifinatamab deruxtecan, raludotatug deruxtecan and docetaxel in previously treated stage IV non-small cell lung cancer patients
GermanyStudy of beta blockers in patients with aortic stenosis undergoing transcatheter aortic valve replacement
AustriaStudy to measure bimekizumab concentration in breast milk of breastfeeding mothers with psoriasis, psoriatic arthritis, axial spondyloarthritis, or hidradenitis suppurativa
GermanyEvaluating Different Durations of Antibiotic Treatment for Respiratory Tract Infections and Rhinosinusitis in Adults Receiving Beta-lactam Antibiotics
SpainStudy of gilteritinib with fludarabine, cytarabine and idarubicin combination therapy in newly diagnosed FLT3-positive acute myeloid leukemia patients
ItalyTell us about your condition – we search every trial in Europe and connect you with the right site.